High throughput screening News and Research

RSS

High-throughput screening (HTS) allows scientists to test thousands of samples at once. These samples can be of a wide variety, and include, but are not limited to, amino acids, chemical compounds or cells.

Could the mTOR pathway be used to protect against cancer?

The mTOR pathway is probably the main pathway in humans and other animals that drives growth. That is, the accumulation of mass and adding mass to make an organism bigger by both making more cells, and making cells grow and become bigger.

22 Jun 2017

Emphasis on nanotechnology, pharmaceutical science, forensics, food safety and bioanalytical for Pittcon's annual call for papers

The Program Committee is pleased to announce the call for papers for the Pittcon 2018 Technical Program. Abstracts are currently being accepted for contributed oral and poster presentations in all areas of analytic chemistry and applied spectroscopy in applications such as, but not limited to, environmental science, food science, energy research, and informatics.

From Pittcon 20 Jun 2017

Penn State scientists win grant to develop novel approach to contraception

Two Penn State researchers have received a grant through the Grand Challenges Explorations program -- an initiative funded by the Bill & Melinda Gates Foundation -- to develop a novel approach to contraception.

15 Jun 2017

Researchers use gene-editing technique to develop new screening tool for Parkinson's disease

A team of researchers at the University of Central Florida is using breakthrough gene-editing technology to develop a new screening tool for Parkinson's disease, a debilitating degenerative disorder of the nervous system.

5 Jun 2017

Researchers identify mechanism to recover aging of Progeria patients

DGIST's research team has identified a mechanism that can recover the aging of patients with Hutchinson-Gilford Progeria Syndrome. DGIST announced that the Chair Professor Park SangChul of New Biology and the research team led by Professor Lee YoungSam has discovered a drug that can improve the aging of HGPS patients and identified the mechanism of aging recovery by using the drug.

4 Apr 2017

Scientists develop novel technique to screen non-coding DNA of genome for diseases

Researchers have developed a method to swiftly screen the non-coding DNA of the human genome for links to diseases that are driven by changes in gene regulation.

4 Apr 2017

Researchers develop new platform for culturing pluripotent stem cells

A team of researchers in Japan has developed a new platform for culturing human pluripotent stem cells that provides far more control of culture conditions than previous tools by using micro and nanotechnologies.

14 Mar 2017

Pittcon 2017: reflections from the floor

Pittcon 2017 commenced with a fascinating talk by world-renowned optogenetics expert Dr. Karl Deisseroth, D.H. Chen Professor of Bioengineering, Psychiatry and Behavioral Sciences, Stanford University and Investigator of the Howard Hughes Medical Institute.

From Pittcon 9 Mar 2017

Bruker showcases innovative high-performance systems and high-value analytical solutions at Pittcon 2017

Bruker (NASDAQ: BRKR) is showcasing a selection of innovative high-performance systems and high-value analytical solutions at Pittcon 2017 (www.pittcon.org), with an emphasis on pharma and applied markets, as well as on nano-materials research and microscopy.

From Bruker BioSpin - NMR, EPR and Imaging 7 Mar 2017

Researchers looking at ways to target lingering cancer stem cells that cause disease relapse

Chemotherapy treatment targets and kills cancer cells in the body. However, even after treatment, some cancer cells may remain in the patient's system undetected.

2 Mar 2017

Novel NMR spectroscopy platform holds potential to revolutionize drug development practices

Implementation of a new nuclear magnetic resonance spectroscopy platform will provide professors Nicolas Doucet and Steven LaPlante of Centre INRS-Institut Armand-Frappier with a powerful new tool for conducting an ambitious research program aimed at identifying new therapeutic molecules.

28 Feb 2017

Scientists develop in vitro stem cell-based bioassay for detecting biological activity of BoNTs

Scientists at the Institute for Infectious Diseases, University of Bern have developed an in vitro stem cell-based bioassay grown on multi-electrode arrays capable of detecting the biological activity of Clostridium botulinum neurotoxins.

28 Feb 2017

BMG LABTECH celebrates 21 years of customer service excellence in the UK

BMG LABTECH’s UK subsidiary has achieved more than two decades of innovation and steady growth. The subsidiary was established in 1996 and 2017 sees its 21st anniversary. It was founded to offer excellent sales and service for BMG LABTECH’s wide range of dedicated and multi-mode microplate readers for life sciences applications and high throughput screening purposes.

From BMG LABTECH GmbH 10 Feb 2017

Integration of Genedata Screener with Nanion SyncroPatch 384PE can take APC experiments to new level

Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced new automated patch clamp (APC) functionality in Genedata Screener for Ion Channel Screening and a Genedata Ready-to-Run integration with Nanion SyncroPatch 384PE.

From Nanion Technologies 3 Feb 2017

Pulmospheres could serve as personalized, predictive model for assessing effect of IPF drugs

Pulmospheres, three dimensional multicellular spheroids composed of lung cells from individual patients, were shown to be effective in predicting the efficacy of medications for idiopathic pulmonary fibrosis, according to findings from University of Alabama at Birmingham scientists presented today in JCI Insight, a journal of the American Society for Clinical Investigation.

27 Jan 2017

TSRI scientists receive $1.8 million grant to develop drug candidates for multiple diseases

Scientists from the Florida campus of The Scripps Research Institute have been awarded approximately $1.8 million from the National Institute of General Medical Sciences of the National Institutes of Health to develop a series of drug candidates for a number of diseases, including heart disease, rheumatoid arthritis and several neurodegenerative disorders.

24 Jan 2017

BMG LABTECH announces integration of entire product range with Genedata Screener

BMG LABTECH collaborates with Genedatato provide a functionally rich integration between BMG LABTCH’s entire product range of dedicated and multi-mode microplate readers and Genedata Screener, a data analysis and management platform for in-vitro screening technologies.

From BMG LABTECH GmbH 20 Jan 2017

Penn researchers discover antimicrobial that thwarts Zika viral entry into human cells

A panel of small molecules that inhibit Zika virus infection, including one that stands out as a potent inhibitor of Zika viral entry into relevant human cell types, was discovered by researchers from the Perelman School of Medicine at the University of Pennsylvania.

17 Jan 2017

BMG LABTECH show off new colour scheme to be implemented on all products

BMG LABTECH’s visual appearance is heading into a new direction. The microplate reader company launched a new corporate colour identity that will be rolled out across all products as well as external and internal communication channels in the coming weeks.

From BMG LABTECH GmbH 12 Jan 2017

Monell Center receives Gates Foundation grant to support innovative global health research project

The Monell Center announced today that it has received a $345,000 grant from the Bill & Melinda Gates Foundation. The grant supports an innovative global health research project titled, "Developing Novel Pediatric Formulation Technologies for Global Health: Human Taste Assays."

1 Dec 2016